HR4525Referred to Committee

Right to FDA-Approved Medicines Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-17
Introduced
29
Cosponsors
HR
ⓘ
Type

Sponsor

Deborah K. Ross
Deborah K. Ross
Democrat · NC · Representative
Votes with party: 99.0% (671 recorded votes)
Top industries funding sponsor:
  • Progressive Groups$78k
  • Climate & Environment$1k

Full profile: /officials/R000305

Source: Congress.gov · FEC

Cosponsors (29)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-07-17

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would allow patients to access medications that the FDA has approved in other countries but not yet approved in the United States, even if those drugs haven't completed the full U.S. approval process. The legislation aims to give terminally ill or seriously ill patients more options when standard treatments aren't working, though it would likely include some safeguards to ensure the drugs meet basic safety standards. The change would affect patients with life-threatening conditions, pharmaceutical companies, and the FDA's drug approval process.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.